Comparative proteomic analysis of paclitaxel resistance-related proteins in human breast cancer cell lines

被引:11
作者
Fujioka, Hiroya [1 ]
Sakai, Akiko [2 ]
Tanaka, Satoru [1 ]
Kimura, Kosei [1 ]
Miyamoto, Akiko [1 ]
Iwamoto, Mitsuhiko [1 ]
Uchiyama, Kazuhisa [1 ]
机构
[1] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Sect Breast & Endocrine Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
[2] Osaka Med Coll, Dept Chem, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
关键词
paclitaxel resistance; proteomics; proteome; breast cancer; peptidyl-prolyl cis-trans isomerase A; III BETA-TUBULIN; COLORECTAL-CANCER; BINDING AGENTS; CYCLOPHILIN; APOPTOSIS; CHEMORESISTANCE; IDENTIFICATION; EXPRESSION; GRP78/BIP; CARCINOMA;
D O I
10.3892/ol.2016.5455
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Paclitaxel is widely used to treat various cancers; however, resistance to this drug is a major obstacle to breast cancer chemotherapy. To identify the proteins involved in paclitaxel resistance, the present study compared the proteomes of MCF-7 human breast cancer cells and its paclitaxel-resistant subclone MCF-7/PTX. Using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time of flight mass spectrometry, 11 upregulated and 12 downregulated proteins were identified in MCF-7/PTX cells compared with the parental cell line. These 23 proteins were functionally classified as stress-induced chaperones, metabolic enzymes and cytoskeletal proteins. The anti-apoptotic proteins, stress-70 protein, 78-kD glucose-regulated protein, peptidyl-prolyl cis-trans isomerase A (PPIA) and heterogeneous nuclear ribonucleoprotein H3, were also upregulated in MCF-7/PTX cells. Notably, knockdown of the stress-response chaperone PPIA using small interfering RNA in MCF-7/PTX cells restored their sensitivity to paclitaxel. These findings indicated that PPIA may have an important role in paclitaxel resistance in MCF-7/PTX cells.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 36 条
[1]   The use of total protein stains as loading controls: An alternative to high-abundance single-protein controls in semi-quantitative immunoblotting [J].
Aldridge, Georgina M. ;
Podrebarac, David M. ;
Greenough, William T. ;
Weiler, Ivan Jeanne .
JOURNAL OF NEUROSCIENCE METHODS, 2008, 172 (02) :250-254
[2]   Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells [J].
Alli, Elizabeth ;
Yang, Jin-Ming ;
Ford, James M. ;
Hait, William N. .
MOLECULAR PHARMACOLOGY, 2007, 71 (05) :1233-1240
[3]   Clinical utility of cytokeratins as tumor markers [J].
Barak, V ;
Goike, H ;
Panaretakis, KW ;
Einarsson, R .
CLINICAL BIOCHEMISTRY, 2004, 37 (07) :529-540
[4]  
CARMICHAEL J, 1987, CANCER RES, V47, P936
[5]   Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death [J].
Choi, Kyu Jin ;
Piao, Yu Ji ;
Lim, Min Jin ;
Kim, Jin Hwan ;
Ha, Joohun ;
Choe, Wonchae ;
Kim, Sung Soo .
CANCER RESEARCH, 2007, 67 (08) :3654-3662
[6]   Messenger-RNA-binding proteins and the messages they carry [J].
Dreyfuss, G ;
Kim, VN ;
Kataoka, N .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (03) :195-205
[7]   GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis [J].
Fu, Yong ;
Li, Jianze ;
Lee, Amy S. .
CANCER RESEARCH, 2007, 67 (08) :3734-3740
[8]   Identification of proteins binding the native tubulin dimer [J].
Gache, V ;
Louwagie, M ;
Garin, J ;
Caudron, N ;
Lafanechere, L ;
Valiron, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 327 (01) :35-42
[9]   Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer [J].
Gan, Pei Pei ;
Pasquier, Eddy ;
Kavallaris, Maria .
CANCER RESEARCH, 2007, 67 (19) :9356-9363
[10]  
Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO